share_log

MEDIROM Healthcare Technologies | 6-K: Report of foreign private issuer (related to financial reporting)

MEDIROM Healthcare Technologies | 6-K: Report of foreign private issuer (related to financial reporting)

MEDIROM Healthcare Technologies | 6-K:外国发行人报告(业绩相关)
美股SEC公告 ·  2024/06/25 19:05

Moomoo AI 已提取核心信息

MEDIROM Healthcare Technologies reported net profit of JPY115 million for FY2023, despite significant investment in healthcare technology systems. Revenue slightly decreased 1.8% to JPY6.83 billion, while Adjusted EBITDA reached JPY306 million with a 4.5% margin.The Relaxation Salon segment saw 1.5% revenue growth to JPY6.06 billion, driven by increased sales per customer to JPY6,852. The company sold 30 salons to investors in 2023 under its sale-and-outsource model. Digital Preventative Healthcare revenue declined 48.1% to JPY200 million due to delays in REMONY system development.The company maintained profitability while advancing its healthcare technology initiatives, including the launch of REMONY Monitoring System. As of May 2024, MEDIROM operates 307 relaxation salons across Japan and has contracts with 81 corporate insurance associations for its Lav health guidance program, serving over 7,200 users.
MEDIROM Healthcare Technologies reported net profit of JPY115 million for FY2023, despite significant investment in healthcare technology systems. Revenue slightly decreased 1.8% to JPY6.83 billion, while Adjusted EBITDA reached JPY306 million with a 4.5% margin.The Relaxation Salon segment saw 1.5% revenue growth to JPY6.06 billion, driven by increased sales per customer to JPY6,852. The company sold 30 salons to investors in 2023 under its sale-and-outsource model. Digital Preventative Healthcare revenue declined 48.1% to JPY200 million due to delays in REMONY system development.The company maintained profitability while advancing its healthcare technology initiatives, including the launch of REMONY Monitoring System. As of May 2024, MEDIROM operates 307 relaxation salons across Japan and has contracts with 81 corporate insurance associations for its Lav health guidance program, serving over 7,200 users.
MEDIROm医疗科技公司发布了2024年5月的关键业绩因子。总体用户数同比从86,895减少到80,512,而每位用户的销售额从6,660日元增加到6,964日元。公司经营了307家美容院,比2023年5月的314家有所下降,重复消费比例略微减少至74.8%,低于75.7%。在其健康科技业务中,MEDIROM的Lav®应用于特定健康指导项目,截至2024年5月已与81家企业保险协会签约,较一年前的68家有所增加。Lav®用户数累计达7,238,显示出这一领域的稳定增长。MEDIROm继续多元化其医疗服务,包括在2023年推出的REMONY,远程监控系统针对企业客户。公司旨在利用其多样化的健康相关产品和服务来收集和管理医疗数据,确立其在医疗行业大数据领域的领导地位。
MEDIROm医疗科技公司发布了2024年5月的关键业绩因子。总体用户数同比从86,895减少到80,512,而每位用户的销售额从6,660日元增加到6,964日元。公司经营了307家美容院,比2023年5月的314家有所下降,重复消费比例略微减少至74.8%,低于75.7%。在其健康科技业务中,MEDIROM的Lav®应用于特定健康指导项目,截至2024年5月已与81家企业保险协会签约,较一年前的68家有所增加。Lav®用户数累计达7,238,显示出这一领域的稳定增长。MEDIROm继续多元化其医疗服务,包括在2023年推出的REMONY,远程监控系统针对企业客户。公司旨在利用其多样化的健康相关产品和服务来收集和管理医疗数据,确立其在医疗行业大数据领域的领导地位。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息